Makakuha ng mabilis at maaasahang mga sagot sa iyong mga tanong sa IDNStudy.com. Ang aming komunidad ay nagbibigay ng eksaktong sagot upang matulungan kang maunawaan at malutas ang anumang problema.
Sagot :
Answer:
Across areas seeing high numbers of coronavirus cases in the Philippines, senior citizens and persons with comorbidities have become the latest group eligible to receive COVID-19 vaccines.
Along with health workers, the two groups form part of the country’s priority populations for the scarce shots.
The government’s coronavirus task force approved the simultaneous vaccinations of these sectors as it expected more doses to become available, though its schedule of deliveries has so far been delayed. The move was also part of efforts to speed up the vaccination program after health officials reported record-high infections in recent weeks.
Medical experts have urged people in the top 3 priority groups to get vaccinated as soon as possible, as they are among those most exposed to COVID-19 and at most risk of developing severe bouts of the disease.
Who is eligible?
Those 60 years old and above, as well as adult Filipinos aged 18-59 with the following diseases will be prioritized while vaccines remain limited, according to the guidelines of the Department of Health:
•Chronic respiratory disease
•Hypertension
•Cardiovascular disease
•Chronic kidney disease
•Cerebrovascular disease
•Malignancy or cancer
•Diabetes
•Obesity
•Chronic liver disease
•Neurologic disease
•Immunodeficiency state
These listed comorbidities are among the top causes of national morbidity and mortality. The diseases had also been found to increase the risk of hospitalization and death due to COVID-19.
In a recent forum, epidemiologist Dr John Wong said data from the Department of Health over the past 18 months showed that though most infections were common among the working population, elderly Filipinos who got infected were 5 times more likely to have severe COVID-19 and 10 times more likely to die.
Explanation:
Sana maka tulong po:))
Pinahahalagahan namin ang bawat ambag mo. Patuloy na magbahagi ng impormasyon at karanasan. Sama-sama tayong magtutulungan upang makamit ang ating mga layunin. Para sa mga de-kalidad na sagot, piliin ang IDNStudy.com. Salamat at bumalik ka ulit sa aming site.